Clinical Trials Browser

OTHER × Interventional × Ursodeoxycholic Acid × Clear all

NCT07378761 2026-01-30

CHILURSO

Phase 2 Not yet recruiting

Neoplasms

NCT00873275 2025-06-22

Ursodiol, Combination Chemotherapy, and Bevacizumab in Treating Patients With Stage IV Colorectal Cancer

Phase 1 Completed

Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT06918080 2025-04-09

Hepatoprotective Measures for Children at High Risk of NAFLD

Phase 4 Active not recruiting

LymphoidOtherOther hematologic neoplasm

Obesity, Overweight, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Non-alcoholic Fatty Liver Disease

NCT01505569 2024-02-26

Auto Transplant for High Risk or Relapsed Solid or CNS Tumors

Phase NA Completed

CNSGastrointestinalGenitourinaryOther solid neoplasmSarcoma

Brain Neoplasms, Carcinoma, Renal Cell, Medulloblastoma, Neoplasms, Germ Cell and Embryonal, Retinoblastoma, Rhabdomyosarcoma, Sarcoma, Central Nervous System Neoplasms, Hepatoblastoma, Rhabdoid Tumor

NCT04810156 2022-12-14

I-HEP

Phase 2 Unknown

Hepatitis, Neoplasms, Chemical and Drug Induced Liver Injury

NCT01149304 2017-11-20

ELDORADO

Phase 2 Completed

Gastrointestinal

Colorectal Neoplasms

NCT00808743 2013-05-16

PreDuoFAP

Phase 2/3 Completed

Gastrointestinal

Adenoma, Digestive System Diseases, Digestive System Neoplasms, Duodenal Neoplasms, Gastrointestinal Diseases, Gastrointestinal Neoplasms, Intestinal Diseases, Intestinal Neoplasms, Neoplastic Syndromes, Hereditary, Adenomatous Polyposis Coli, Polyps, Adenomatous Polyps, Genetic Diseases, Inborn

NCT00062023 2012-07-30

Comparison of Sulindac, Aspirin, and Ursodiol in Preventing Colorectal Cancer

Phase 2 Terminated

Gastrointestinal

Colonic Neoplasms, Colorectal Neoplasms

NCT00134758 2009-07-29

Ursodeoxycholic Acid in the Treatment of Duodenal Adenomas in Familial Adenomatous Polyposis (FAP) Patients

Phase 2/3 Unknown

Gastrointestinal

Adenoma, Adenomatous Polyposis Coli